- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: November 2014
- Public Summary Document (PSD) November 2014 PBAC Meeting - PDF
- Public Summary Document (PSD) November 2014 PBAC Meeting - Word
Buprenorphine + naloxone – November 2014
Buprenorphine + naloxone; 4mg/1mg film: sublingual, 12mg/3mg film: sublingual, Suboxone®
Last updated
6 March 2015